Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we herein mention the schedule of Analyst / Institutional Investor Meeting with the Company

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Management of the Company will be holding one-on-one meetings or group meetings with investors in Singapore as part... More> f a Non-Deal Roadshow organised by ICICI Securities Limited from 19th May 2025 to 21th May 2025.<Less

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyCipla Ltd 2CIN NO.L24239MH1935PLC002380 3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00... More> 4Highest Credit Rating during the previous FY AAA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Rajendra Chopra Designation: Company Secretary and Compliance Officer EmailId: cosecretary?cipla.com Name of the Chief Financial Officer: Ashish Adukia Designation: Global Chief Financial Officer EmailId: cosecretary?cipla.com Date: 29/04/2025 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. <Less

Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

Please find enclosed disclosure on ESG rating.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 17th April 2025 has allotted 23282 fully paid up equity... More> res of INR 2/- each pursuant to exercise of employee stock options under the Employee Stock Option Scheme 2013-A of the Company.<Less

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the schedule of Earnings Conference Call to be held on 13th May 2025.

Update On USFDA Inspection At Manufacturing Facility Of Medispray In Kundaim Goa India

Update on USFDA inspection at manufacturing facility of Medispray in Kundaim Goa India

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

Company has received final approval from USFDA for ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound) 100 mg/vial Single-Dose Vial (Protein-bound Paclitaxel) on 10th April 2025

Board Meeting Intimation for Quarter And Year Ended 31St March 2025 Under SEBI Listing Regulations

Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve 1. the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2025.... More> 2. Recommend final dividend for the year ended 31st March 2025 if any. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Tuesday 1st April 2025 till Thursday 15th May 2025 (both days inclusive) for the purpose of financial results.<Less

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 19th March 2025 has allotted 2179 fully paid up equity shares of INR 2 each pursuant to exercise of... More> ployee stock options/stock appreciation rights under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.<Less

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Notice of Postal Ballot dated 3rd September 2024

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 12th September 2024 has allotted 7059 fully paid up equity... More> shares of the INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.<Less

Corrigendum - Outcome Of Board Meeting Held On 3Rd September 2024

Corrigendum - Outcome of Board meeting held on 3rd September 2024

Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd September 2024

Outcome of Board meeting held on 3rd September 2024

Announcement under Regulation 30 (LODR)-Change in Directorate

Change in Directors of the Company

Announcement under Regulation 30 (LODR)-Change in Directorate

Mr. Adil Zainulbhai and Mr. Ashok Sinha are completing their second term as an independent director on 2nd September 2024.

Transcript Of The 88Th Annual General Meeting

Please find enclosed the transcript of the 88th Annual General Meeting of the Company held on Tuesday 20th August 2024 through video conferencing/ other audio-visual means.

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Shareholder Meeting / Postal Ballot-Outcome of AGM

Proceedings of the 88th Annual General Meeting.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company will hold one-on-one meetings or group meetings with investors in the United States of... More> ica as part of a Non-Deal Roadshow.<Less

Shareholder Meeting / Postal Ballot-Scrutinizers Report

Details of voting results of the 88th Annual General Meeting of the Company and Scrutinisers report

Announcement under Regulation 30 (LODR)-Change in Management

Retirement of Mr. S. Radhakrishnan as Non-Executive Director of the Company

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Further to our intimation dated 3rd August 2024 on the schedule of analyst / institutional investor meeting we would like to intimate that the mode of meeting for 7th August 2024 with Macquarie Group has changed from in-person to virtual. All other details of the... More> osure remain the same.<Less

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we herein mention the schedule of Analyst / Institutional Investor Meeting with the Company.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and the Administrative Committee of the Company on 2nd August 2024 has allotted 6815 fully paid up... More> quity shares of the INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.<Less

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

We are enclosing herewith copy of the transcript of the Companys Q1 FY25 earnings conference call held on 26th July 2024

Announcement under Regulation 30 (LODR)-Newspaper Publication

Enclosing herewith copies of newspaper advertisement published in Business Standards and Sakal today 27th July 2024.

Reg. 34 (1) Annual Report.

Notice of the 88th Annual General Meeting along with a copy of the Integrated Annual Report for FY 2023-24

Notice Of The 88Th Annual General Meeting Along With A Copy Of The Integrated Annual Report For FY 2

Notice of the 88th Annual General Meeting along with a copy of the Integrated Annual Report for FY 2023-24

Announcement under Regulation 30 (LODR)-Change in Directorate

Change in directors of the Company.

Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation dated 26th July 2024

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release for quarter ended 30th June 2024

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the earnings conference call for Q1 FY25 held today is available on the Companys website at... More> ipla.com/audio/12007<Less

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release for quarter ended 30th June 2024

Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2024

Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30th June 2024

Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Report for FY 2023-24

Announcement under Regulation 30 (LODR)-Change in Management

Appointment of SMP

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HDFC Mutual Fund

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication of consolidated unaudited financial results for the quarter ended 30th June 2024

Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th July 2024

Outcome of the Board Meeting held on 26th July 2024

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we herein mention the schedule of Analyst/Institutional Investor Meetings with Company

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed Newspaper advertisement titled Notice of 88th AGM to be held through Video Conference / Other Audio-Visual Means Record date and Final Dividend published in the Business Standard and Sakal on 18th July 2024.

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Pleas find enclosed intimation pursuant to Regulation 74(5) of SEBI (DP) Regulations

USFDA Inspection At CompanyS Manufacturing Facility In Kurkumbh Maharashtra India

USFDA inspection at Companys manufacturing facility in Kurkumbh Maharashtra India

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the schedule of Earnings Conference Call to be held on 26th July 2024.

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find enclosed the intimation regarding issuance of letter of confirmation

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 4th July 2024 has allotted 35106 fully paid-up equity... More> s of INR 2 each pursuant to exercise of employee stock options/stock appreciation rights under Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company<Less

Dissolution Of Wholly Owned Step-Down Subsidiary

Dissolution of wholly owned step-down subsidiary

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obliga

CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2024.

Dissolution Of Wholly Owned Step-Down Subsidiary

Dissolution of Cipla Dibcare (Pty) Limited i.e. wholly owned step-down subsidiary of the Company

Update On USFDA Inspection At CompanyS Manufacturing Facility In Patalganga Maharashtra India

Update on USFDA inspection at Companys manufacturing facility in Patalganga Maharashtra India

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for BlackRock Inc

USFDA Inspection At CompanyS Manufacturing Facility In Goa India.

USFDA inspection at Companys manufacturing facility in Goa India

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find enclosed the intimation for loss of share certificates

Press Release- Cipla EU To Invest Additional EUR 3 Million In Ethris

Press Release- Cipla EU to invest additional EUR 3 million in Ethris

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find enclosed the intimation for loss of share certificate

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find the newspaper publication

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 10th June 2024 has allotted 72263 fully paid up equity shares... More> f INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Employee Stock Option Scheme 2013-A and Employee Stock Appreciation Rights Scheme 2021 of the Company.<Less

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find enclosed the intimation for loss of share certificates

Announcement under Regulation 30 (LODR)-Change in Management

Change in Senior Management Personnel

Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find the attached Annual Secretarial Compliance Report for the Financial Year ended 31st March 2024

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find the attached intimation of loss of share certificate

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we herein mention the schedule of Analyst / Institutional Investor Meetings with the Company.

Cipla Receives Final Approval For The Generic Version Of Somatuline® Depot (Lanreotide) Injection

Cipla receives final approval for the generic version of Somatuline (R) Depot (Ianreotide) Injection

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find enclosed the intimation for loss of shares certificate

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Please find the attached Result of Postal Ballot and Scrutinizers report

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrations Committee of the Company on 16th May 2024 has allotted 50768 fully paid-up equity shares of INR... More> 2 each pursuant to exercise of ESOPs/ESARs under the ESOP scheme 2013-A and ESAR scheme 2021 of the Company. Consequently the issued subscribed and paid-up capital of the Company stands increased to INR 1614891472 comprising of 807445736 equity shares of face value INR 2 each.<Less

Clarification W.R.T. Sale Of Shares By The Promoter Group

Clarification w.r.t. sale of shares by the Promoter Group is enclosed.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samina Hamied & Others

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

We are enclosing herewith copy of the transcript of the Companys Q4 FY24 earnings conference call dated 10th May 2024.

Announcement under Regulation 30 (LODR)-Acquisition

Cipla Limited has entered into definitive agreements on 15th May 2024 for further investment of upto INR 26 crores in Achira Labs Private Limited associate company.

Announcement under Regulation 30 (LODR)-Change in Management

Resignation of Senior Management Personnel

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release for Q4 & FY24 financial results

Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th May 2024

Outcome of board meeting held on 10th May 2024

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication

Grant Of Stock Options And Employee Stock Appreciation Rights

Grant of Stock options and employee stock appreciation rights

Financial Results And Declaration Of Dividend

Please find enclosed the result dated 10th May 2024

Announcement under Regulation 30 (LODR)-Dividend Updates

Recommendation of Final dividend for FY 2023-2024

Announcement under Regulation 30 (LODR)-Change in Management

Appointment of Senior Management Personnel

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the earnings conference call for Q4 FY 24.

Appointment Of Cost Auditor For FY 2024-25

Appointment of Cost Auditor for FY 2024-25

Record Date For Payment Of Final Dividend For FY 2023-24

Record date for payment of final dividend for FY 2023-24

Announcement under Regulation 30 (LODR)-Investor Presentation

Investor presentation for Q4 & FY24 financial results

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Company will hold one-on-one or group meetings with investors in Singapore as part of a Non-Deal Roadshow organized... More> y Investec Capital Services (India) Private from 15th May 2024 to 17th May 2024.<Less

USFDA Inspection At CompanyS Manufacturing Facility In Kurkumbh Maharashtra India.

USFDA inspection at Companys manufacturing facility in Kurkumbh Maharashtra India.

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Announcement under Regulation 30 (LODR)-Updates on Acquisition

Update on purchase of business undertaking on a slump sale arrangement from Ivia Beaute Private Limited India..

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding issuance of letter of confirmation under Regulation 39(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Reg

Please find enclosed the Certificate from a PCS in compliance with Regulation 40(9) of the SEBI (LODR) Regulations 2015

Notice Of Postal Ballot

In compliance with regulation 30 of Listing Regulations we had submitted the Notice of Postal Ballot dated 11th April 2024 on 16th April 2024 with the BSE. We noted that due to technical reasons the said intimation is not visible on the BSE website. As per advise from... More> BSE we are re-submitting the said intimation. We request you to please take the above intimation on record in compliance with the Listing Regulations requirements.<Less

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find the attached newspaper publication.

Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirem

Compliance certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Certificate under Regulation 74(5) of SEBI (Depositories Participant) Regulations 2018

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 15th April 2024 has allotted 27906 fully paid-up equity shares of... More> NR 2 each pursuant to exercise of ESOPs under the Employee Stock Option Scheme 2013-A of the Company. Consequently the issued subscribed and paid-up Capital of the Company stands increased to INR 1614789936 comprising of 807394968 equity shares of face value INR 2 each.<Less

Announcement under Regulation 30 (LODR)-Acquisition

Acquisition of a business undertaking from Ivia Beaute Private Limited India

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the schedule of Earnings Conference Call to be held on 10th May 2024.

Board Meeting Intimation for Quarter And Year Ended 31St March 2024 Under SEBI Listing Regulations

CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve 1. Consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year... More> ended 31st March 2024. 2. Recommend final dividend for the year ended 31st March 2024 if any. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Monday 1st April 2024 till Sunday 12th May 2024 (both days inclusive) for the purpose of financial results.<Less

USFDA Inspection At CompanyS Manufacturing Facility In Patalganga Maharashtra India

USFDA inspection at Companys manufacturing facility in Patalganga Maharashtra India

Announcement under Regulation 30 (LODR)-Change in Management

Pursuant to Regulation 30 of the SEBI Listing Regulations we hereby notify that Mr. Rajeev Kumar Sinha presently working as Global Head - Formulations Manufacturing has been appointed as Senior Management Personnel and Global Chief Manufacturing Officer w.e.f. 1st... More> l 2024.<Less

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India

Announcement under Regulation 30 (LODR)-Restructuring

Merger of Cipla Technologies LLC USA with Cipla USA Inc. USA wholly owned step down subsidiaries of the Company

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI Listing Regulation.

Announcement under Regulation 30 (LODR)-Change in Management

Further to the intimation filed on 15th March 2024 with respect to appointment of Mr. Venkata Sai Mungara as Senior Management Personnel and Global Head - Supply Chain of the Company we are re-submitting the same intimation affixing DSC in compliance with requirement... More> f circulars issued by BSE and NSE. We confirm that there is no change in the information.<Less

Announcement under Regulation 30 (LODR)-Change in Management

Mr. Sai Venkata Mungara presently working as Vice-president and Head Regional Supply Chain North America has been appointed as Senior Management Personnel and Global Head - Supply Chain of the Company w.e.f. 1st April 2024

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 15th March 2024 has allotted 1658 fully paid-up equity shares of... More> R 2 each pursuant to exercise of ESOPs / ESARs under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company. Consequently the issued subscribed and paid-up Capital of the Company stands increased to INR 1614734124 comprising of 807367062 equity shares of face value INR 2 each.<Less

Disclosure Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosur

We hereby notify that Goldencross Pharma Limited wholly owned subsidiary of the Company has completed the sale of its entire shareholding in Wellthy Therapeutics Private Limited in terms of the definitive agreement executed on 6th March 2024.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Company will hold one-on-one / group meetings with investors in London as part of a Non-Deal Roadshow organized by... More> tak Institutional Equities from 12th March 2024 to 14th March 2024.<Less

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we herein mention the schedule of Analyst / Institutional Investor Meetings with the Company.

Update On Transfer Of Generics Business Undertaking Of The Company To Cipla Pharma And Life Sciences

Update on transfer of Generics Business Undertaking of the Company to Cipla Pharma and Life Sciences Limited wholly owned subsidiary of the Company

Announcement under Regulation 30 (LODR)-Updates on Acquisition

Update on incorporation of a joint venture company in USA

USFDA Inspection At Manufacturing Facility In Qidong Jiangsu Province China

USFDA inspection at manufacturing facility in Qidong Jiangsu Province China

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) and other applicable regulations of the SEBI (listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Registrar and Share Transfer agent of the Company M/S KFin Technologies Limited has received... More> intimation for loss of share certificate and request for issuance of duplicate share certificates<Less

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 15th February 2024 has allotted 5863 fully paid-up equity... More> hares of INR 2 each pursuant to exercise of ESOPs / ESARs under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company. Consequently the issued subscribed and paid-up share capital of the Company stands increased to INR 1614730808 comprising of 807365404 equity shares of face value INR 2 each.<Less

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding issuance of Letter of Confirmation under Regulation 39(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 (Listing Regulation).

Announcement under Regulation 30 (LODR)-Investor Presentation

In furtherance to our intimation dated 1st December 2023 with respect to our participation at the Nuvama India Conference 2024 the presentation to be discussed at the conference is enclosed and the same is also available on our website at www.cipla.com.

Announcement under Regulation 30 (LODR)-Updates on Acquisition

Further to our intimation dated 14th December 2023 we hereby notify that closing conditions stated in definitive agreements signed by the Company on 14th December 2023 have been met on 2nd February 2024 and the Company has completed acquisition and subscription of... More> tional shares in Goapptiv Private Limited associate Company. Accordingly Cipla will now hold 22.99% stake on a fully dilutive basis in Goapptiv.<Less

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

We are enclosing herewith copy of the transcript of the Companys Q3FY24 earnings conference call dated 25th January 2024.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the earnings conference call for Q3 FY 24.

Announcement under Regulation 30 (LODR)-Change in Directorate

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as enclosed.

Announcement under Regulation 30 (LODR)-Acquisition

Cipla (EU) Limited UK and Cipla Holding BV Netherlands wholly owned subsidiaries of the Company have jointly incorporated Mexicip S.A.de C.V. a wholly owned subsidiary in Mexico w.e.f. 22 January 2024.

Announcement under Regulation 30 (LODR)-Investor Presentation

Please find the enclosed investor presentation for Q3FY24 unaudited financial result.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find the attached enclosed the press release dated 22nd January 2024.

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find the attached extract of the consolidated unaudited financial results for the quarter ended 31st December 2023 to be published in newspaper.

Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results (Standalone And Cons

Please find the attached Unaudited financial results.

Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31ST

The Board of Directors of the company at its meeting held on 22nd December 2023 has approved unaudited consolidated and standalone financial results.

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We hereby notify that in compliance with Regulation 39(3) of the SEBI listing regulations read with SEBI circular dated 25th January 2022 the Company has approved the issuance of Letter of Confirmation in lieu of duplicate share certificates which were reported as lost... More> by the shareholders.<Less

Update on board meeting

The Board Meeting to be held on 25/01/2024 has been revised to 22/01/2024 The Board Meeting to be held on 25/01/2024 has been revised to 22/01/2024

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations

Intimation under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is enclosed herewith.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 18th January 2024 has allotted 1899 fully paid-up equity shares of... More> INR 2 each pursuant to exercise of ESOPs / ESARs under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company. Consequently the issued subscribed and paid-up share capital of the Company stands increased to INR 1614719082 comprising of 807359541 equity shares of face value INR 2 each.<Less

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Pursuant to regulation 74(5) of SEBI (DP) regulations 2018 we enclose herewith a copy of the certificate received from Kfin Technologies Limited the Registrar and Share Transfer Agent of the Company